These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys. Minervini V, Disney A, Husbands SM, France CP. Psychopharmacology (Berl); 2020 Oct 27; 237(10):3057-3065. PubMed ID: 32772146 [Abstract] [Full Text] [Related]
14. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception. Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS. J Pharmacol Exp Ther; 2003 Dec 27; 307(3):1054-64. PubMed ID: 14557380 [Abstract] [Full Text] [Related]
18. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity. McLaughlin JP, Hill KP, Jiang Q, Sebastian A, Archer S, Bidlack JM. J Pharmacol Exp Ther; 1999 Apr 27; 289(1):304-11. PubMed ID: 10087018 [Abstract] [Full Text] [Related]
19. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Negus SS, Mello NK, Linsenmayer DC, Jones RM, Portoghese PS. Psychopharmacology (Berl); 2002 Oct 27; 163(3-4):412-9. PubMed ID: 12373442 [Abstract] [Full Text] [Related]